Market Closed - Nasdaq Copenhagen 16:20:00 12/09/2024 BST 5-day change 1st Jan Change
922.80 DKK -0.35% Intraday chart for Coloplast A/S +3.04% +19.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
COLOPLAST : Q3 24: Chronic care momentum makes up for urology pain Alphavalue
Jyske Bank Downgrades Coloplast to Hold, Trims PT MT
Global markets live: Rio Tinto, GSK, Palo Alto, GM, Lowe's... Our Logo
Coloplast Sticks to 2024 Guidance as Fiscal Third Quarter Revenue Beats, Profit Misses MT
Transcript : Coloplast A/S, Nine Months 2024 Earnings Call, Aug 20, 2024
Coloplast's Fiscal Q3 Net Profit Flatlines; Revenue Rises MT
Coloplast A/S Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2024 CI
Coloplast A/S Re-Affirms Earnings Guidance for the Fiscal Year 2023/24 CI
Powell's Hint Hunt Our Logo
AlphaValue/Baader Europe Downgrades Coloplast to Reduce, Trims PT MT
Barclays Upgrades Coloplast to Overweight, Lifts PT MT
Danske Bank Upgrades Coloplast to Buy from Hold MT
Transcript : Coloplast A/S - Analyst/Investor Day
COLOPLAST : Multiple silver linings in spite of a soft Q2 24 Alphavalue
European shares hit one-month high as earnings take centre stage RE
European shares hit one-month high on upbeat earnings, rate-cut optimism RE
Transcript : Coloplast A/S, H1 2024 Earnings Call, May 07, 2024
Coloplast Posts Higher Fiscal H1 Net Profit, Revenue MT
Coloplast Strengthens Ostomy Care Portfolio with Three Significant Product Launches CI
Coloplast A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
Coloplast A/S Revises Earnings Guidance for the Fiscal Year 2023/24 CI
Coloplast A/S Announces Interim Dividend for the First Half of 2023/24, Payable on May 15, 2024 CI
Certain B Shares of Coloplast A/S are subject to a Lock-Up Agreement Ending on 27-FEB-2024. CI
COLOPLAST : Q1 24: Many more positives beyond the margin beat Alphavalue
Nordic Shares Moved Upward Friday; Kongsberg Gruppen Topped Leaders DJ
Chart Coloplast A/S
More charts
Logo Coloplast A/S
Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Employees
16,019
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
922.80DKK
Average target price
915.60DKK
Spread / Average Target
-0.78%
Consensus
  1. Stock Market
  2. Equities
  3. COLO B Stock
  4. News Coloplast A/S
  5. Barclays Upgrades Coloplast to Overweight, Lifts PT
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW